Rank	NCT Number	Title	Acronym	Status	Study Results	Conditions	Interventions	Outcome Measures	Sponsor/Collaborators	Gender	Age	Phases	Enrollment	Funded Bys	Study Type	Study Designs	Other IDs	Start Date	Primary Completion Date	Completion Date	First Posted	Results First Posted	Last Update Posted	Locations	Study Documents	URL
1	NCT01724047	Autism Intervention Research Network for Behavioral Health (AIR-B II): Deployment Into Elementary Schools	AIR-B II	Completed	No Results Available	Autism	Behavioral: Playground Intervention|Behavioral: STAT Intervention	Playground Intervention: Playground Peer Engagement|Playground Intervention: Social Network Salience|STAT Intervention: Teacher Behaviors and Student's Engagement in the Classrooms|Playground Intervention: Teachers Ratings of Intervention Implementation|Playground Intervention: Teacher's Perceptions of Intervention|STAT Intervention: Teacher Nominated Target Behaviors|Playground Intervention Teacher's Perceptions of Intervention|Playground Intervention: Coach Ratings of Aide Implementation|Playground Intervention: Observer Ratings of Aide Implementation|Playground Intervention: Observer Ratings of Aides Implementation|STAT Intervention: Coach Rated Teacher Implementation|STAT Intervention: Teacher Ratings of Implementation|Playground Intervention: Aides Ratings of Effectiveness of Intervention|STAT Intervention: Teachers Ratings of Effectiveness of Intervention	Health Resources and Services Administration (HRSA)|University of Rochester|University of Pennsylvania	All	4 Years and older   (Child, Adult, Older Adult)	Not Applicable	250	U.S. Fed|Other	Interventional	Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment	12-001120	November 2012	June 2014	June 2014	November 9, 2012		September 25, 2014	UCLA Semel Institute, Los Angeles, California, United States|University of Rochester Medical Center, Rochester, New York, United States|UPENN Map Center for Mental Health Policy and Services Research, Philadelphia, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT01724047
2	NCT00953095	Social and Communication Outcomes for Young Children With Autism		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Joint Attention Intervention	Early Social Communication Scale|Mullen Scales of Early Learning	Health Resources and Services Administration (HRSA)|University of California, Los Angeles|University of Washington|University of Michigan|Florida State University|Johns Hopkins University	All	24 Months to 60 Months   (Child)	Not Applicable	112	U.S. Fed|Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Treatment	G09-02-016-01|UA3MC11055	April 2009	December 2011	December 2011	August 6, 2009		September 25, 2014	University of California, Los Angles, Los Angeles, California, United States|Florida State University, Tallahassee, Florida, United States|Kennedy Krieger Institute, Baltimore, Maryland, United States|University of Michigan, Ann Arbor, Michigan, United States|University of Washington, Seattle, Washington, United States		https://ClinicalTrials.gov/show/NCT00953095
3	NCT01011764	Study of Peer Relationships at School	HRSAII	Completed	No Results Available	Autism	Behavioral: SKILLS vs ENGAGE	The Friendship Survey|Friendship Qualities Scale	Health Resources and Services Administration (HRSA)|Florida State University|Johns Hopkins University|University of Michigan|University of Washington	All	7 Years to 12 Years   (Child)	Not Applicable	200	U.S. Fed|Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment	G09-04-021-01A|UA3MC11055	September 2009	June 2012	August 2012	November 11, 2009		August 16, 2012	University of California, Los Angeles, Los Angeles, California, United States|Florida State University, Tallahassee, Florida, United States|Kennedy Krieger Institute, Baltimore, Maryland, United States|University of Michigan, Ann Arbor, Michigan, United States|University of Washington, Seattle, Washington, United States		https://ClinicalTrials.gov/show/NCT01011764
4	NCT02222662	Parent-delivered Massage for Children With Autism - Ages 6 to 11		Completed	No Results Available	Autism	Other: Parent massage tx group|Other: Parent massage wait-list control group	Change in severity of autism|Change in developmental skills	Western Oregon University|HRSA/Maternal and Child Health Bureau	All	6 Years to 11 Years   (Child)	Not Applicable	35	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	R40MC24945(2)	June 2014	February 2016	February 2016	August 21, 2014		April 29, 2016	Various locations in Portland, Salem, Albany/Corvallis and Eugene, Portland, Salem, Albany, Corvallis, Eugene, Oregon, United States		https://ClinicalTrials.gov/show/NCT02222662
5	NCT00057408	A Controlled Study of Olanzapine in Children With Autism		Completed	No Results Available	Autistic Disorder	Drug: olanzapine (Zyprexa)|Drug: Placebo	Children's Psychiatric Rating Scale|Clinical Global Impressions|Aberant Behavior Checklist|Treatment Emergent Symptoms Scale|Olanzapine Untoward Effects Checklist|Abnormal Involuntary Movement Scale|Neurological Rating Scale	FDA Office of Orphan Products Development|National Institute of Mental Health (NIMH)	All	3 Years to 12 Years   (Child)	Phase 2	78	U.S. Fed|NIH	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	2190	May 2003		September 2005	April 2, 2003		March 25, 2015	Drexel University College of Medicine c/o Friends Hospital, Philadelphia, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT00057408
6	NCT01801696	Parent-delivered Massage for Children With Autism		Completed	No Results Available	Autism	Other: Parent massage tx group|Other: Parent massage wait-list control group	Severity of autism|Developmental skills	Western Oregon University|HRSA/Maternal and Child Health Bureau	All	2 Years to 5 Years   (Child)	Phase 2|Phase 3	103	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	R40MC24945(1)	September 2012	November 2014	March 2016	March 1, 2013		April 29, 2016	Various locations in Albany and Corvallis, Corvallis, Oregon, United States|Various locations in Eugene, Oregon, Eugene, Oregon, United States|Various locations in Portland, Oregon, Portland, Oregon, United States|Various locations in Salem, Oregon, Salem, Oregon, United States		https://ClinicalTrials.gov/show/NCT01801696
7	NCT02871349	Trial of Propranolol in Children and Youth With Autism Spectrum Disorder and Predictors of Response		Completed	No Results Available	Autism Spectrum Disorder	Drug: Propranolol|Drug: Placebo|Device: Magnetic Resonance Imaging (MRI)	Change in General Social Outcomes Measure (GSOM) Assessment|Change in Social Responsiveness Scale (SRS-2)|Change in score on Anagrams test|Change in Semantic fluency test results|Change Clinical Global Impression surveys|Change in Autism Impact Measure (AIM)|Change in Clinical Evaluation of Language Fundamentals (CELF-5) assessment|Change in Vineland Adaptive Behavior Scales (VABS-2) assessment|Change in score on Aberrant Behavior Checklist (ABC)|Change in gastrointestinal symptomology	University of Missouri-Columbia|United States Department of Defense	All	7 Years to 24 Years   (Child, Adult)	Early Phase 1	69	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	2005213	August 2016	August 2020	August 2020	August 18, 2016		October 8, 2020	Thompson Center for Autism & Neurodevelopmental Disorders, Columbia, Missouri, United States	"Study Protocol", https://ClinicalTrials.gov/ProvidedDocs/49/NCT02871349/Prot_000.pdf	https://ClinicalTrials.gov/show/NCT02871349
8	NCT01908205	Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism Spectrum Disorders (ASD)	OXY-R	Completed	Has Results	Autism Spectrum Disorder	Drug: Intranasal Oxytocin|Drug: Placebo	Efficacy of Intranasal Oxytocin vs. Placebo on Measures of Social Function|Efficacy of Intranasal Oxytocin vs. Placebo on Measures of Social Cognition|Number of Participant Considered Social Responders|Efficacy of Intranasal Oxytocin vs. Placebo on Measures of Repetitive Behaviors|Efficacy of Intranasal Oxytocin vs. Placebo on Measures of Anxiety|Efficacy of Intranasal Oxytocin vs. Placebo on Measures of Quality of Life|Number of Participant Considered Overall Responders|Safety and Tolerability of Intranasal Oxytocin in Children and Adolescents With ASD	Evdokia Anagnostou|United States Department of Defense|Anagnostou, Evdokia, M.D.	All	10 Years to 17 Years   (Child)	Phase 2	60	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	OXY-R07-2013	September 2013	September 2015	March 2016	July 25, 2013	November 16, 2020	November 16, 2020	University of Minnesota, Minneapolis, Minnesota, United States|Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT01908205
9	NCT03338530	Efficacy of a Comprehensive School-based Intervention for High-functioning Children With Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Comprehensive School-Based Intervention	Change from Baseline Cambridge Mindreading Face-Voice Battery for Children (CAM-C) Scores at Follow-up|Change from Baseline Social Responsiveness Scale, 2nd Edition, School Age Form (SRS-2) Scores at Follow-up|Change from Baseline Adapted Skillstreaming Checklist (ASC) Scores at Follow-up|Change from Baseline Woodcock-Johnson III Tests of Achievement (WJ III ACH) Scores at Follow-up|Change from Baseline Social Interaction Observation Scale (SIOS) Scores at Follow-up	Canisius College|U.S. Department of Education	All	6 Years to 12 Years   (Child)	Not Applicable	103	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	2012-13#142RENEWAL-Ammend	August 1, 2013	July 31, 2017	July 31, 2017	November 9, 2017		November 9, 2017			https://ClinicalTrials.gov/show/NCT03338530
10	NCT04936009	Transcranial Magnetic Stimulation (TMS) Study for Adults With Autism Spectrum Disorder (ASD)		Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Transcranial Magnetic Stimulation (TMS)	right hemisphere N170 latency|proportion of visual attention to the eye region of the face	Yale University|United States Department of Defense	All	18 Years to 40 Years   (Adult)	Not Applicable	60	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Treatment	2000030576|Proposal No. AR200174	March 17, 2022	July 1, 2024	July 1, 2024	June 23, 2021		May 25, 2022	Yale University Child Study Center, New Haven, Connecticut, United States		https://ClinicalTrials.gov/show/NCT04936009
11	NCT04446442	Cerebellar tDCS in Children With Autism Spectrum Disorder		Recruiting	No Results Available	Autism Spectrum Disorder	Device: tDCS	Incidence of tDCS associated side effects assessed by tDCS Safety Assessment|Change in Autism Spectrum Disorder Symptoms assessed by NEPSY-2 Subtests|Change in Autism Spectrum Disorder Symptoms assessed by Reading the Mind in the Eyes|Change in Autism Spectrum Disorder Symptoms assessed by Triangle Animations/Social Perception Task|Change in Autism Spectrum Disorder Symptoms assessed by Cyberball/Social Ball Throwing Task|Change in Autism Spectrum Disorder Symptoms assessed by Dimensional Change Card Sort|Change in Autism Spectrum Disorder Symptoms assessed by Autism Spectrum Rating Scale	University of Texas Southwestern Medical Center|United States Department of Defense	All	4 Years to 17 Years   (Child)	Not Applicable	60	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Other	UTSW 022017-071	June 4, 2019	December 2023	July 2024	June 25, 2020		December 2, 2021	Children's Medical Center, Dallas, Texas, United States|University of Texas Southwestern, Dallas, Texas, United States		https://ClinicalTrials.gov/show/NCT04446442
12	NCT03984487	Daily Living Skills Intervention for Adolescents With Autism Spectrum Disorder		Active, not recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Surviving and Thriving in the Real World|Behavioral: Program for the Education and Enrichment of Relational Skills	Vineland Adaptive Behavior Scales, 3rd Edition	Children's Hospital Medical Center, Cincinnati|United States Department of Defense	All	15 Years to 22 Years   (Child, Adult)	Not Applicable	64	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	CIN-DUNCAN-2018-2886	May 17, 2018	June 30, 2022	August 31, 2023	June 13, 2019		December 15, 2021	Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States		https://ClinicalTrials.gov/show/NCT03984487
13	NCT02385799	A Trial of Sertraline in Young Children With Autism Spectrum Disorder	Sert2	Completed	Has Results	Autism Spectrum Disorder	Drug: Sertraline Liquid Placebo|Drug: Sertraline	Change in Mullen Scales of Early Learning - Expressive Language Raw Score|Change in Mullen Scales of Early Learning - Combined Age Equivalent Score|Vineland Adaptive Behavior Scales, Second Edition (Vineland-II) Adaptive Behavior Composite Standard Score|Preschool Anxiety Scale-Revised - Total Score|Preschool Language Scale-Fifth Edition - Total Language Raw Score|Sensory Processing Measure-Preschool - Social Participation Raw Score|Clinical Global Impression Scale-Severity (CGI-S)|Clinical Global Impression Scale-Improvement (CGI-I)|Visual Analog Scale - Language/Communication Score	Randi J. Hagerman, MD|Health Resources and Services Administration (HRSA)|University of California, Davis	All	24 Months to 72 Months   (Child)	Phase 2	58	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	663866	April 2015	July 2018	July 2018	March 11, 2015	May 9, 2019	October 22, 2019	UC Davis MIND Institute, Sacramento, California, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/99/NCT02385799/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT02385799
14	NCT01800539	Improving Services and Outcomes for Children With Autism Spectrum Disorder (ASD)		Completed	No Results Available	Autism Spectrum Disorders	Behavioral: Provider Education Model (PEM)	Change in Provider Delivery Service Practices|Change in Baseline Mullen Scales of Early Learning|Change in Baseline Autism Diagnostic Observation Schedule|Change in Caregiver Interaction with Child	Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|Health Resources and Services Administration (HRSA)	All	12 Months to 42 Months   (Child)	Not Applicable	80	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	NA_00023642	February 2014	June 2022	June 2022	February 27, 2013		July 8, 2022	Kennedy Krieger Institute, Baltimore, Maryland, United States		https://ClinicalTrials.gov/show/NCT01800539
15	NCT03711799	Mind the Gap (AIR-B3)	MtG	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Access to services via peer coaching	Change in Service Access Form from month to month|Family Empowerment Scale (Koren, DeChillo & Friesen, 1992)|Caregiver Agency Questionnaire (adapted from Kuhn & Carter, 2006)|Caregiver Autism Knowledge Questionnaire (adapted, Kuhn & Carter, 2006)|Caregiver Stigma Scale (McKay & Cavaleri, 2009)|Satisfaction Survey|Community Capital Scale|Social Dynamics of Intervention_ASD (Autism Spectrum Disorder)-SoDI	Health Resources and Services Administration (HRSA)|University of Rochester|University of Pennsylvania|University of California, Davis|Drexel University	All	2 Years and older   (Child, Adult, Older Adult)	Not Applicable	156	U.S. Fed|Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	17-000029	April 1, 2018	August 1, 2020	August 31, 2020	October 18, 2018		February 9, 2022	UC Davis, Davis, California, United States|University of Rochester, Rochester, New York, United States|UPENN, Philadelphia, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT03711799
16	NCT04545606	Targeting Insomnia in School Aged Children With Autism Spectrum Disorder	RECHArge	Recruiting	No Results Available	Insomnia Chronic|Autism Spectrum Disorder	Behavioral: In-Person CBT for insomnia in children with autism|Behavioral: Remote CBT for insomnia in children with autism|Behavioral: Remote sleep hygiene and related education (SHARE) for insomnia in children with autism	Baseline Average Objective Sleep Efficiency for the child|Change in Average Objective Sleep Efficiency for the child from baseline to immediately after the intervention|Change in Average Objective Sleep Efficiency for the child from baseline to 6 months|Change in Average Objective Sleep Efficiency for the child from baseline to 12 months|Baseline Average Bed/Waketime Variability for the child|Change in Average Bed/Waketime Variability for the child from baseline to immediately after the intervention|Change in Average Bed/Waketime Variability for the child from baseline to 6 months|Change in Average Bed/Waketime Variability for the child from baseline to 12 months|Baseline Average RMSDNN (root mean squared st. dev. of N-N intervals) for the child|Change in Average RMSDNN (root mean squared st. dev. of N-N intervals) for the child from baseline to immediately after the intervention|Change in Average RMSDNN (root mean squared st. dev. of N-N intervals) for the child from baseline to 6 months|Change in Average RMSDNN (root mean squared st. dev. of N-N intervals) for the child from baseline to 12 months|Baseline Average Objective Total Sleep Time for the parent|Change in Average Objective Total Sleep Time for the parent from baseline to immediately after the intervention|Change in Average Objective Total Sleep Time for the parent from baseline to 6 months|Change in Average Objective Total Sleep Time for the parent from baseline to 12 months|Baseline Aberrant Behavior Checklist (ABC) for the child|Aberrant Behavior Checklist (ABC) for the child immediately after the intervention|Aberrant Behavior Checklist (ABC) for the child at 6 months|Aberrant Behavior Checklist (ABC) for the child at 12 months|Baseline Conners' Continuous Performance Test - 3rd Edition (CCPT-3) for a child (ages 8+)|Conners' Continuous Performance Test - 3rd Edition (CCPT-3) for a child (ages 8+) immediately after the intervention|Conners' Continuous Performance Test - 3rd Edition (CCPT-3) for a child (ages 8+) at 6 months|Conners' Continuous Performance Test - 3rd Edition (CCPT-3) for a child (ages 8+) at 12 months|Baseline Conners' Kiddie Continuous Performance Test (K-CPT) for a child (ages 6-7)|Conners' Kiddie Continuous Performance Test (K-CPT) for a child (ages 6-7) immediately after the intervention|Conners' Kiddie Continuous Performance Test (K-CPT) for a child (ages 6-7) at 6 months|Conners' Kiddie Continuous Performance Test (K-CPT) for a child (ages 6-7) at 12 months|Baseline Behavior Rating Inventory of Executive Function - 2nd Edition (BRIEF-2) for the child|Behavior Rating Inventory of Executive Function - 2nd Edition (BRIEF-2) for the child immediately after the intervention|Behavior Rating Inventory of Executive Function - 2nd Edition (BRIEF-2) for the child at 6 months|Behavior Rating Inventory of Executive Function - 2nd Edition (BRIEF-2) for the child at 12 months|Baseline Child and Adolescent Symptom Inventory - 4th Edition Revised (CASI-4R) for the child|Child and Adolescent Symptom Inventory - 4th Edition Revised (CASI-4R) for the child immediately after the intervention|Child and Adolescent Symptom Inventory - 4th Edition Revised (CASI-4R) for the child at 6 months|Child and Adolescent Symptom Inventory - 4th Edition Revised (CASI-4R) for the child at 12 months|Baseline Child Quality of Life: PedsQL Child Form for the child|Child Quality of Life: PedsQL Child Form for the child immediately after the intervention|Child Quality of Life: PedsQL Child Form for the child at 6 months|Child Quality of Life: PedsQL Child Form for the child at 12 months|Baseline Child Quality of Life: PedsQL Parent Form for the child|Child Quality of Life: PedsQL Parent Form for the child immediately after the intervention|Child Quality of Life: PedsQL Parent Form for the child at 6 months|Child Quality of Life: PedsQL Parent Form for the child at 12 months|Baseline Average Subjective Sleep Onset Latency for the child|Change in Average Subjective Sleep Onset Latency for the child from baseline to immediately after the intervention|Change in Average Subjective Sleep Onset Latency for the child from baseline to 6 months|Change in Average Subjective Sleep Onset Latency for the child from baseline to 12 months|Baseline Average Subjective Total Wake Time for the child|Change in Average Subjective Total Wake Time for the child from baseline to immediately after the intervention|Change in Average Subjective Total Wake Time for the child from baseline to 6 months|Change in Average Subjective Total Wake Time for the child from baseline to 12 months|Baseline Average Subjective Total Sleep Time for the child|Change in Average Subjective Total Sleep Time for the child from baseline to immediately after the intervention|Change in Average Subjective Total Sleep Time for the child from baseline to 6 months|Change in Average Subjective Total Sleep Time for the child from baseline to 12 months|Baseline Average Subjective Sleep Efficiency for the child|Change in Average Subjective Sleep Efficiency for the child from baseline to immediately after the intervention|Change in Average Subjective Sleep Efficiency for the child from baseline to 6 months|Change in Average Subjective Sleep Efficiency for the child from baseline to 12 months|Baseline Average LF/HF ratio for the child|Change in Average LF/HF ratio for the child from baseline to immediately after the intervention|Change in Average LF/HF ratio for the child from baseline to 6 months|Change in Average LF/HF ratio for the child from baseline to 12 months|Baseline Average pNN50 (% of N-N intervals > 50 ms) for the child|Change in Average pNN50 (% of N-N intervals > 50 ms) for the child from baseline to immediately after the intervention|Change in Average pNN50 (% of N-N intervals > 50 ms) for the child from baseline to 6 months|Change in Average pNN50 (% of N-N intervals > 50 ms) for the child from baseline to 12 months|Baseline Average LF/HF ratio for the parent|Change in Average LF/HF ratio for the parent from baseline to immediately after the intervention|Change in Average LF/HF ratio for the parent from baseline to 6 months|Change in Average LF/HF ratio for the parent from baseline to 12 months|Baseline Average pNN50 (% of N-N intervals > 50 ms) for the parent|Change in Average pNN50 (% of N-N intervals > 50 ms) for the parent from baseline to immediately after the intervention|Change in Average pNN50 (% of N-N intervals > 50 ms) for the parent from baseline to 6 months|Change in Average pNN50 (% of N-N intervals > 50 ms) for the parent from baseline to 12 months|Baseline Average RMSDNN (root mean squared st. dev. of N-N intervals) for the parent|Change in Average RMSDNN (root mean squared st. dev. of N-N intervals) for the parent from baseline to immediately after the intervention|Change in Average RMSDNN (root mean squared st. dev. of N-N intervals) for the parent from baseline to 6 months|Change in Average RMSDNN (root mean squared st. dev. of N-N intervals) for the parent from baseline to 12 months|Baseline State-Trait Anxiety Inventory (STAI-Y1) for the parent|State-Trait Anxiety Inventory (STAI-Y1) for the parent immediately after the intervention|State-Trait Anxiety Inventory (STAI-Y1) for the parent at 6 months|State-Trait Anxiety Inventory (STAI-Y1) for the parent at 12 months|Baseline Beck Depression Inventory (BDI-II) for the parent|Beck Depression Inventory (BDI-II) for the parent immediately after the intervention|Beck Depression Inventory (BDI-II) for the parent at 6 months|Beck Depression Inventory (BDI-II) for the parent at 12 months|Baseline Fatigue Severity Scale for the parent|Fatigue Severity Scale for the parent immediately after the intervention|Fatigue Severity Scale for the parent at 6 months|Fatigue Severity Scale for the parent at 12 months|Baseline Daily Fatigue for the parent|Daily Fatigue for the parent immediately after the intervention|Daily Fatigue for the parent at 6 months|Daily Fatigue for the parent at 12 months|Baseline Caregiver Strain Index (CSI) for the parent|Caregiver Strain Index (CSI) for the parent immediately after the intervention|Caregiver Strain Index (CSI) for the parent at 6 months|Caregiver Strain Index (CSI) for the parent at 12 months|Baseline Average Subjective Sleep Onset Latency for the parent|Change in Average Subjective Sleep Onset Latency for the parent from baseline to immediately after the intervention|Change in Average Subjective Sleep Onset Latency for the parent from baseline to 6 months|Change in Average Subjective Sleep Onset Latency for the parent from baseline to 12 months|Baseline Average Subjective Total Wake Time for the parent|Change in Average Subjective Total Wake Time for the parent from baseline to immediately after the intervention|Change in Average Subjective Total Wake Time for the parent from baseline to 6 months|Change in Average Subjective Total Wake Time for the parent from baseline to 12 months|Baseline Average Subjective Total Sleep Time for the parent|Change in Average Subjective Total Sleep Time for the parent from baseline to immediately after the intervention|Change in Average Subjective Total Sleep Time for the parent from baseline to 6 months|Change in Average Subjective Total Sleep Time for the parent from baseline to 12 months|Baseline Average Subjective Sleep Efficiency for the parent|Change in Average Subjective Sleep Efficiency for the parent from baseline to immediately after the intervention|Change in Average Subjective Sleep Efficiency for the parent from baseline to 6 months|Change in Average Subjective Sleep Efficiency for the parent from baseline to 12 months	University of Missouri-Columbia|United States Department of Defense	All	6 Years to 12 Years   (Child)	Not Applicable	180	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2019182|W81XW-H2010399	September 15, 2020	August 2025	August 2030	September 11, 2020		March 31, 2022	Thompson Center for Autism and Neurodevelopmental Disorders, Columbia, Missouri, United States		https://ClinicalTrials.gov/show/NCT04545606
17	NCT04972838	AIR-B4: Remaking Recess (RR)	RR	Recruiting	No Results Available	Autism Spectrum Disorder|Neurodevelopmental Disorders	Behavioral: Remaking Recess (RR)	Stages of Implementation Completion (SIC)|School Implementation Climate Scale|Social Network Survey- participants of survey will name key personnel that can be participants of the UNITED team for this intervention|Teacher Perceptions Scale|Clinical Global Rating (CGI)	Health Resources and Services Administration (HRSA)|University of California, Davis|University of Kansas|University of Washington|University of Pennsylvania|University of Rochester|Drexel University	All	5 Years to 12 Years   (Child)	Not Applicable	264	U.S. Fed|Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	20-001993	July 11, 2021	August 31, 2025	December 1, 2025	July 22, 2021		October 11, 2021	University of Rochester, Rochester, New York, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Washington, Seattle, Washington, United States		https://ClinicalTrials.gov/show/NCT04972838
18	NCT04972825	AIR-B4: Mind the Gap	MTG	Recruiting	No Results Available	Autism Spectrum Disorder|Neurodevelopmental Disorders	Behavioral: Mind the Gap	Stages of Implementation Completion (SIC)|School Implementation Climate Scale (SICS)|Change in Coaching Session Data Form from month to month|Family Empowerment Scale (Koren, DeChillo & Friesen, 1992)|WHOQOL scale|Social Network Survey|Caregiver Satisfaction Survey	Health Resources and Services Administration (HRSA)|University of Rochester|University of Kansas|University of Pennsylvania|Drexel University|University of California, Davis|University of Washington	All	2 Years and older   (Child, Adult, Older Adult)	Not Applicable	308	U.S. Fed|Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	20-001403	July 29, 2021	August 1, 2025	August 31, 2025	July 22, 2021		July 26, 2022	UC Davis MIND Institute, Davis, California, United States|University of Kansas, Lawrence, Kansas, United States|University of Rochester, Rochester, New York, United States|UPENN, Philadelphia, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT04972825
19	NCT04972851	AIRB-4: Self-Determined Learning Model of Instruction	SDLMI	Recruiting	No Results Available	Autism Spectrum Disorder|Neurodevelopmental Disorders	Behavioral: Self-Determined Learning Model of Instruction (SDLMI)	Stages of Implementation Completion (SIC)|School Implementation Climate Scale|Self-Determination Inventory (SDI-SR)|Goal Attainment Scaling (GAS)|Social Network Survey	Health Resources and Services Administration (HRSA)|University of California, Davis|University of Kansas|University of Washington|University of Pennsylvania|University of Rochester|Drexel University	All	13 Years and older   (Child, Adult, Older Adult)	Not Applicable	358	U.S. Fed|Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	20-002001	August 4, 2021	August 31, 2025	December 1, 2025	July 22, 2021		October 11, 2021	UC Davis MIND Institute, Davis, California, United States|University of Kansas, Lawrence, Kansas, United States|University of Washington, Seattle, Washington, United States		https://ClinicalTrials.gov/show/NCT04972851
20	NCT03668873	Telehealth Delivery of Treatment for Sleep Disturbances in Young Children With Autism Spectrum Disorder		Active, not recruiting	No Results Available	Autism Spectrum Disorder|Sleep Disturbance	Behavioral: Sleep Parent Training|Behavioral: Sleep Parent Education	Improvement in Sleep Disturbances|Parental Quality of Life: PSOC	The Cleveland Clinic|United States Department of Defense	All	2 Years to 7 Years   (Child)	Not Applicable	90	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	AR170155	November 1, 2018	January 1, 2023	January 1, 2023	September 13, 2018		August 31, 2022	Cleveland Clinic Lerner School for Autism, Cleveland, Ohio, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/73/NCT03668873/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT03668873
21	NCT03445520	Building Better Bridges Randomized Control Trial	(AIR-B3)	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Intervention Coaching Group	Transition Evaluation Questionnaire (TEQ)|Engagement vs.Disaffection|Social Dynamics of Intervention_ASD (Autism Spectrum Disorder)- SoDI|Parent Engagement (ESE)|Community Capital|Usability & Acceptability Form|Strategies Survey|Transition Practices|Burnout Measure|School Situations Questionnaire (SSQ)	Health Resources and Services Administration (HRSA)|University of Rochester|University of Pennsylvania|University of California, Davis|Drexel University	All	Child, Adult, Older Adult	Not Applicable	375	U.S. Fed|Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	17-001459	March 15, 2018	March 31, 2020	August 31, 2020	February 26, 2018		February 9, 2022	UC Davis, Davis, California, United States|University of Rochester, Rochester, New York, United States|UPENN, Philadelphia, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT03445520
22	NCT05425277	Assessing the Effectiveness of Reciprocal Imitation Teaching in Part C Early Intervention Settings (Sprout Study)		Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Reciprocal Intervention Teaching (RIT)|Behavioral: Daily Routines	Child Social Communication - In Vivo|Child Social Communication - Parent Report|Child Social Communication - Behaviorally Coded|Child Motor Imitation - In Vivo|Child Motor Imitation - Parent Report|Provider Coaching of Caregivers in RIT Strategies|Caregiver Use of RIT Strategies|Child Adaptive Behavior|Child Language|Parenting Self-Efficacy|Parenting Stress|Caregiver Top Concerns	University of Washington|Congressionally Directed Medical Research Programs	All	18 Months to 80 Years   (Child, Adult, Older Adult)	Not Applicable	180	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	STUDY00007803|W81XWH1910293	May 15, 2021	July 14, 2023	July 14, 2023	June 21, 2022		June 21, 2022	University of Washington, Seattle, Washington, United States		https://ClinicalTrials.gov/show/NCT05425277
23	NCT04505488	Efficacy of the ASPEN Intervention Program in Low-Resource Communities	ASPEN	Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: ASD Screening Parent ENgagement Intervention Program (ASPEN)	Adaptive Behavior|Parenting Stress|Parent Empowerment|Child Challenging Behavior|Family Quality of Life	Texas State University, San Marcos|National Institute on Disability, Independent Living, and Rehabilitation Research	All	18 Months to 6 Years   (Child)	Not Applicable	320	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	90IFST0004	July 7, 2020	June 30, 2022	June 30, 2022	August 10, 2020		May 24, 2022	Texas State University, San Marcos, Texas, United States		https://ClinicalTrials.gov/show/NCT04505488
24	NCT04001790	Effect of a 9-Month Internship Intervention for Military Dependents With ASD		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Project Search plus ASD Supports	Change in Competitive Integrated Employment rates|Change in Number of hours worked|Change in hourly Wage earned|Change in Social responsiveness|Quality of Life of Individual with ASD|Change in anxiety|Change in Depression	Virginia Commonwealth University|United States Department of Defense	All	18 Years to 21 Years   (Adult)	Not Applicable	38	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	HM20008778|CDMRP AR150172	May 11, 2017	May 19, 2021	May 19, 2021	June 28, 2019		June 3, 2021	Virginia Commonwealth University, Richmond, Virginia, United States	"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/90/NCT04001790/ICF_000.pdf	https://ClinicalTrials.gov/show/NCT04001790
25	NCT01591707	Evaluating a Social and Communication Intervention for Preschoolers		Active, not recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: ISC+PRT Intervention	Change in educator instruction to meet fidelity of intervention.|Change in Baseline Autism Diagnostic Observation Schedule|Change in Baseline Mullen Scales of Early Learning|Change in Child's Baseline Spontaneous Imitation Task|Change in Child Classroom-based Social Communication Performance|Change in parent perception of child behavior as recorded by the Autism Composite score of the PDDBI (parent version)	Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|U.S. Department of Education	All	3 Years to 6 Years   (Child)	Not Applicable	700	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	NA_00073501	July 2012	March 2023	March 2023	May 4, 2012		June 3, 2022	Brennen School, Newark, Delaware, United States|Kennedy Krieger Institute/Howard County Public Schools, Baltimore, Maryland, United States|Elwyn Early Childhood Services, Media, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT01591707
26	NCT03560453	Facilitating Employment for Youth With Autism		Completed	No Results Available	Autism Spectrum Disorder|Autism|Asperger Syndrome|Pervasive Developmental Disorder|Adolescent Development	Behavioral: Project SEARCH Plus ASD Supports	Change in Employment Outcomes Survey from Graduation to 12 months follow-up|Change in the Support Intensity Scale (SIS; Thompson, et al., 2004) from Graduation to 12 months follow-up|Change in Social Responsiveness Scale, Second Edition (Constantino & Gruber, 2012) from Graduation to 12 months follow-up|Change in The ARC's Self-Determination Scale (Wehmeyer, 1996) from from Graduation to 12 months follow-up|Change in The Short Form 36 Version 2 (SF-36v2, Maurish & Turner-Bowker, 2009) from from Graduation to 12 months follow-up	Virginia Commonwealth University|National Institute on Disability, Independent Living, and Rehabilitation Research	All	18 Years to 22 Years   (Adult)	Not Applicable	162	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	HM15031|NIDILRRDRRP13-16	August 1, 2013	March 15, 2018	March 15, 2018	June 18, 2018		July 31, 2018			https://ClinicalTrials.gov/show/NCT03560453
27	NCT01008800	A Randomized Clinical Trial for Toddlers With ASD		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Social Communication|Behavioral: Social communication	Communication and Symbolic Behavior Scales|Mullen Scales of Early Learning	Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|HRSA/Maternal and Child Health Bureau	All	22 Months to 33 Months   (Child)	Not Applicable	196	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	R40 MC 15594-01|NA_00030329	September 2009	February 2013	February 2013	November 6, 2009		March 10, 2021	Kennedy Krieger Institute, Baltimore, Maryland, United States		https://ClinicalTrials.gov/show/NCT01008800
28	NCT04369417	Evaluation of a Resiliency Intervention for Siblings of Children With Autism Spectrum Disorder (ASD)	SibChat	Completed	No Results Available	Stress	Behavioral: Relaxation Response Resiliency Program for Siblings of Children with ASD	Feasibility assessed by the number participants enrolled.|Feasibility assessed by the number SibChat-3RP of sessions attended|Feasibility assessed by the survey retention post intervention.|Acceptability assessed using the participant feedback survey|Acceptability assessed by relaxation response adherence|Effectiveness of trial on improving stress coping ability (assessed using Measure of Current Status-A)|Effectiveness of trial on improving resiliency (assessed using Current Experiences Scale)|Pre-post intervention changes as measured by change in primary outcome scores of resiliency and stress coping.|Sustained improvements in primary outcomes of resiliency and stress coping as measured by sustained change in primary outcome scores.	Massachusetts General Hospital|Health Resources and Services Administration (HRSA)	All	14 Years to 17 Years   (Child)	Not Applicable	44	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2019P003218	January 28, 2020	January 1, 2021	January 1, 2021	April 30, 2020		April 5, 2022	Massachusetts General Hospital, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT04369417
29	NCT03202303	Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)		Recruiting	No Results Available	Autism Spectrum Disorder	Drug: Cannabidivarin|Drug: Matched Placebo	Aberrant Behavior Checklist-Irritability Subscale (ABC-I)|Repetitive Behavior Scale-Revised (RBS-R)|Aberrant Behavior Checklist-Social Withdrawal Subscale (ABC-SW)|Pediatric Quality of Life Inventory (PedsQL) Family Impact Module|Vineland Adaptive Behavior Scale-3 (Vineland 3)|Clinical Global Impressions-Improvement (CGI-I)|Montefiore Einstein Rigidity Scale-Revised (MERS-R)	Montefiore Medical Center|United States Department of Defense|Jazz Pharmaceuticals	All	5 Years to 18 Years   (Child, Adult)	Phase 2	100	Other|U.S. Fed|Industry	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	2017-8538|AR160104|G32379	April 12, 2019	July 31, 2023	July 31, 2023	June 28, 2017		September 22, 2022	Montefiore Medical Center, Bronx, New York, United States		https://ClinicalTrials.gov/show/NCT03202303
30	NCT04612231	Examining the Efficacy of the T-STEP		Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: TEACCH School Transition to Employment and Postsecondary Education (T-STEP)|Behavioral: Counseling Services Alone	Change in Becker Work Adjustment Profile-2 (BWAP) Scores from Baseline to Post-Intervention|Change in Behavioral Rating Inventory of Executive Function, Adult Version (BRIEF-A) Scores from Baseline to Post-Intervention|Change in Transition Readiness and Employability Evaluation (TREE) Scores from Baseline to Post-Intervention|Change in The American Institutes for Research Self-Determination Scale (AIR) Scores from Baseline to Post-Intervention|Change in Coping Self-Efficacy Scale (CES) Scores from Baseline to Post-Intervention|Change in Center for Epidemiological Studies - Depression, Revised (CESD-R) Scores|Change in State Trait Anxiety Inventory (STAI) Trait Scale Scores|Student Adaptation to College Questionnaire (SACQ)|Change in Grade Point Average (GPA)|Change in Employment Status Categorizations|Change in Becker Work Adjustment Profile-2 (BWAP) Scores from Post-Intervention to 4 Month Follow Up|Change in Behavioral Rating Inventory of Executive Function, Adult Version (BRIEF-A) Scores from Post-Intervention to 4 Month Follow Up|Change in The American Institutes for Research Self-Determination Scale (AIR) Scores from Post-Intervention to 4 Month Follow Up|Change in Coping Self-Efficacy Scale (CES) Scores from Post-Intervention to 4 Month Follow Up|Change in Activities of Daily Living (WADL) Scores|Change in Clinical Global Impression Scale (CGI) Scores from Baseline to Post-Intervention	University of North Carolina, Chapel Hill|United States Department of Defense	All	16 Years to 21 Years   (Child, Adult)	Not Applicable	144	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	19-0627|CDMRP-R180178-A	December 11, 2020	August 2023	August 2023	November 2, 2020		August 2, 2022	University of North Carolina, Chapel Hill, North Carolina, United States|Johnston Community College, Clayton, North Carolina, United States|Alamance Community College, Graham, North Carolina, United States|Guilford Technical Community College, Greensboro, North Carolina, United States|Wake Tech Community College, Raleigh, North Carolina, United States		https://ClinicalTrials.gov/show/NCT04612231
31	NCT03685474	Facing Your Fears in Schools: Implementing a CBT Program for Students With ASD or Other Special Learning Needs	FYF-SB	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Facing Your Fears - School Based|Behavioral: Usual Care	Reduction in symptoms of anxiety of the participant as measured by scores from the teacher - completed questionnaire, The School Anxiety Scale (SAS).|Reduction in symptoms of anxiety of participants as measured by scores from the parent-completed questionnaire, Parent-Rated Anxiety Scale for ASD (PRAS-ASD).|Reduction in symptoms of anxiety of participant as measured by scores from parent -, and self - completed questionnaire, Screening for Childhood Anxiety and Related Emotional Disorders (SCARED).|Reduction in symptoms of anxiety of participants as measured by scores from parent - completed questionnaire, The Social Responsiveness Scale, Second Edition (SRS-2).|Reduction in symptoms of anxiety of participants as measured by scores from parent -, and teacher - completed questionnaire, Emotion Regulation Checklist (ERC).|Classroom attendance|Protocol adherence as measured by fidelity checklist.|Emotion Dysregulation Inventory Scores: Dysphoria|Emotion Dysregulation Inventory Scores: Reactivity|Teacher Concern Inventory: Time Management Subscale|Teacher Concern Inventory: Work Stressors|Teacher Concern Inventory: Professional Distress|Teacher Concern Inventory: Discipline and Motivation|Teacher Concern Inventory: Professional Investment	University of Colorado, Denver|Health Resources and Services Administration (HRSA)	All	8 Years to 14 Years   (Child)	Not Applicable	389	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	18-0114	August 1, 2018	June 1, 2020	June 1, 2020	September 26, 2018		September 30, 2021	University of Colorado School of Medicine, Aurora, Colorado, United States	"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/74/NCT03685474/ICF_000.pdf	https://ClinicalTrials.gov/show/NCT03685474
32	NCT03560297	SeRenade Parent-Child Music Class Program		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: SeRenade Parent-Child Music Class|Behavioral: Delayed Intervention	Motor Imitation Scale|Actions & Gestures|Parenting Stress Index, 4th edition Short Form|Parenting Efficacy/Quality|Parent-Child Interaction|social visual attention eye-tracking paradigm	Vanderbilt University Medical Center|National Endowment for the Arts, United States	All	20 Months to 72 Months   (Child)	Not Applicable	70	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other	160784	May 15, 2018	December 23, 2019	March 20, 2020	June 18, 2018		February 8, 2022	Vanderbilt University Medical Center, Nashville, Tennessee, United States		https://ClinicalTrials.gov/show/NCT03560297
33	NCT02561481	Sulforaphane Treatment of Children With Autism Spectrum Disorder (ASD)		Completed	Has Results	Autism Spectrum Disorder	Drug: Sulforaphane|Drug: Placebo	Change in Ohio Autism Clinical Impressions Scale - Improvement (OACIS-I) Average Score From Baseline|OACIS-I Response Rate on Aberrant Behaviors Subscale|OACIS-I Response Rate on Social Communication Subscale|Change in Total Aberrant Behavior Checklist Score From Baseline|Change in Total SRS-2 Score From Baseline|Dithiocarbamate Plasma Concentration Detected by Cyclocondensation at Each Visit|Comparison of Free Reduced Glutathione (GSH), Total GSH, Oxidized Glutathione (GSSG) at Week 0 and 15|Free GSH:GSSG and Total GSH:GSSG Ratios at Week 15	University of Massachusetts, Worcester|Congressionally Directed Medical Research Programs|Johns Hopkins University	All	3 Years to 12 Years   (Child)	Phase 1|Phase 2	60	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	H00007832|AR140087	December 2015	December 2018	January 2020	September 28, 2015	November 25, 2020	December 17, 2020	University of Massachusetts Medical School, Worcester, Massachusetts, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/81/NCT02561481/Prot_SAP_000.pdf|"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/81/NCT02561481/ICF_001.pdf	https://ClinicalTrials.gov/show/NCT02561481
34	NCT03197922	Encopresis & MIE (DoD #2)		Active, not recruiting	No Results Available	Encopresis|Autism Spectrum Disorder	Combination Product: MIE Treatment	Number of Children Achieving Continence|Clinical Global Impression Scale - Improvement (CGI-I) Score|Change in Parenting Stress Index Short Form Score|Change in Caregiver Strain Questionnaire - Short Form Score	Emory University|United States Department of Defense	All	5 Years to 12 Years   (Child)	Phase 3	138	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	IRB00095849	October 25, 2017	February 2023	February 2023	June 23, 2017		September 23, 2022	Marcus Autism Center, Atlanta, Georgia, United States		https://ClinicalTrials.gov/show/NCT03197922
35	NCT05176808	Telehealth Parent-Implemented Intervention for Young Children With Autism Spectrum Disorder (ASD)		Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Early Achievements- Parent Coaching Intervention	Child Duration of Joint Attention|Parent Fidelity of Implementation	Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|United States Department of Defense|Johns Hopkins Bloomberg School of Public Health	All	18 Months to 33 Months   (Child)	Not Applicable	188	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	IRB00279093	February 7, 2022	June 1, 2025	January 1, 2026	January 4, 2022		April 7, 2022	Kennedy Krieger Institute, Baltimore, Maryland, United States		https://ClinicalTrials.gov/show/NCT05176808
36	NCT04654260	Behavior Therapy for Irritability in Autism	BTIA	Recruiting	No Results Available	Autism Spectrum Disorder|Irritability|Disruptive Behavior|Anger|Aggression|Asperger Syndrome|Pervasive Developmental Disorder	Behavioral: Behavioral Therapy for Irritability in Autism|Behavioral: Psychoeducation and Supportive Therapy (PST)	Modified Overt Aggression Scale (MOAS)|The Clinical Global Impression - Improvement Score (CGI-I)|Irritability subscale - Aberrant Behavioral Checklist|Vineland Adaptive Behavior Scales - Communication Domain Score	Yale University|Congressionally Directed Medical Research Programs	All	12 Years to 18 Years   (Child, Adult)	Not Applicable	126	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	0102012121-5|W81XWH2010718	December 10, 2020	August 30, 2024	December 1, 2024	December 4, 2020		May 19, 2022	Yale Child Study Center, New Haven, Connecticut, United States		https://ClinicalTrials.gov/show/NCT04654260
37	NCT05268796	Telehealth-Enabled Versus In-Person Parent-Mediated Behavioral Treatment for Challenging Behaviors in Children With ASD		Not yet recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Behavior therapy|Other: Psychoeducation	Aberrant Behavior Checklist - Community|Parenting Stress Index	Stanford University|Behavior Change Institute|United States Department of Defense	All	3 Years to 5 Years   (Child)	Phase 2|Phase 3	180	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	AR210221	June 2022	June 2026	June 2026	March 7, 2022		April 20, 2022			https://ClinicalTrials.gov/show/NCT05268796
38	NCT01086475	D-Cycloserine and Social Skills Training in Autism Spectrum Disorders		Completed	Has Results	Autistic Disorder|Asperger's Disorder|Pervasive Developmental Disorder NOS	Drug: D-cycloserine|Drug: Placebo	Social Responsiveness Scale (SRS) Change|Social Responsiveness Scale (SRS) at Follow-Up|Clinical Global Impressions Improvement Scale Responder Analysis	Indiana University|United States Department of Defense	All	5 Years to 11 Years   (Child)	Phase 3	68	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	0906-09	March 2010	January 2014	January 2014	March 15, 2010	April 14, 2016	April 14, 2016	Riley Hospital for Children, Indianapolis, Indiana, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States		https://ClinicalTrials.gov/show/NCT01086475
39	NCT05031364	CBT for Youth With Autism and Emotional/Behavioral Needs in Community Care Settings	CYAN	Recruiting	No Results Available	Autism	Behavioral: Behavioral Interventions for Anxiety in Children with Autism (BIACA)|Behavioral: Treatment-as-Usual Supplemented by Internet-Based Self-Instruction (MEYA)	Change in Aberrant Behavior Checklist-2 Irritability Subscale (ABC-2)|Change in Pediatric Anxiety Rating Scale (PARS)|Change in Social Responsiveness Scale II (SRS-II)|Consumer Satisfaction Parent Questionnaire	University of California, Los Angeles|Virginia Commonwealth University|United States Naval Medical Center, San Diego|Westside Regional Center	All	6 Years to 14 Years   (Child)	Not Applicable	100	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	AR200108	July 1, 2021	March 1, 2025	June 30, 2025	September 1, 2021		September 1, 2021	Westside Regional Center, Culver City, California, United States|Naval Medical Center San Diego, San Diego, California, United States		https://ClinicalTrials.gov/show/NCT05031364
40	NCT01021384	Supporting the Well Being of Families of Young Children With Autism Spectrum Disorders		Completed	No Results Available	Maternal Depression	Behavioral: Problem Solving Education	Quick Inventory of Depressive Symptoms|Parenting Stress Index|Perceived Stress Scale|Social Problem Solving Inventory|Social Adjustment Scale Self-Report|Patient Activation Measure	Boston Medical Center|HRSA/Maternal and Child Health Bureau	Female	Child, Adult, Older Adult	Phase 3	122	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care	H-28799	September 2009	August 2012	March 2013	November 30, 2009		April 29, 2013	Boston Medical Center, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT01021384
41	NCT05131425	Facing Your Fears: Adolescents With ASD and Intellectual Disability	FYF:ASD/ID	Recruiting	No Results Available	Autism Spectrum Disorder|Intellectual Disability|Anxiety	Behavioral: Facing Your Fears: ASD/ID|Other: Treatment as Usual	Change in number of anxiety diagnoses as measured by the Anxiety Disorders Interview Schedule: Autism Addendum (ADIS:ASA)|Change in the Clinical Global Improvement-Severity score as derived by the Anxiety Disorders Interview Schedule: Autism Addendum (ADIS:ASA)|Change in the Reactivity subscale as assessed by the Emotion Dysregulation Inventory (EDI)|Change in the Dysphoria subscale as assessed by the Emotion Dysregulation Inventory (EDI)|Change in problem behavior as assessed by the The Aberrant Behavior Checklist-Community (ABC-C)	University of Colorado, Denver|United States Department of Defense	All	12 Years to 18 Years   (Child, Adult)	Not Applicable	72	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	20-3142	September 1, 2021	August 2024	August 2024	November 23, 2021		December 13, 2021	University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States|University of Colorado, Aurora, Colorado, United States		https://ClinicalTrials.gov/show/NCT05131425
42	NCT04060017	Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium		Suspended	No Results Available	Autism Spectrum Disorder|Language Disorders	Drug: Levoleucovorin Calcium|Other: Placebo	Evaluate the change in measures of expressive language|Evaluate the change in measures of receptive language|Evaluate the safety and tolerability of L-leucovorin calcium in young children with ASD|Evaluate the safety of L-leucovorin calcium in young children with ASD|Evaluate the overall change in core autism symptoms of social communication|Evaluate the change in stereotypical autism symptoms|Evaluate the change in social withdrawal autism symptoms|Evaluate the change in effects of autism symptoms most problematic to family members|Evaluate change in overall autism severity|Evaluate the change in overall cognitive ability|Evaluate the change in adaptive functioning	Rossignol Medical Center|State University of New York - Downstate Medical Center|United States Department of Defense|Southwest Autism Research & Resource Center	All	30 Months to 60 Months   (Child)	Phase 2	80	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	DOD Leucovorin	September 22, 2020	January 2023	January 2023	August 16, 2019		September 28, 2022	Southwestern Research & Resource Center, Phoenix, Arizona, United States|State University of New York, Downstate, Brooklyn, New York, United States		https://ClinicalTrials.gov/show/NCT04060017
43	NCT05056922	Telehealth Rapid Intervention for Externalizing Behaviors in ASD	THRIVE-ASD	Enrolling by invitation	No Results Available	Autism Spectrum Disorder|Disruptive Behavior|Externalizing Behavior|Parent-Child Interaction Therapy|Telehealth	Behavioral: Tele-PCIT|Behavioral: Treatment as Usual	Change in Child Behavior Problems as assessed by Eyberg Child Behavior Inventory (ECBI)|Change in Child Behavior Problems as assessed by Sutter-Eyberg Student Behavior Inventory-Revised (SESBI-R)|Change in Child Compliance and Parent Interaction as assessed by Dyadic Parent-Child Interaction Coding System, 4th edition (DPICS-IV)|Change in Parenting Practices as assessed by Parenting Scale (PS)|Change in Parenting Stress as assessed by Parenting Stress Index-Short Form (PSI-SF)|Change in Child Behavior Problems as assessed by Behavior Assessment System for Children-3rd Edition (BASC-3)|Change in Child Behavior Problems as assessed by Disruptive Behavior Disorders Rating Scale (DBD)|Parent Satisfaction with Tele-PCIT as assessed by Therapy Attitude Inventory (TAI)|Impact of Barriers on Treatment Engagement as assessed by Barriers to Treatment Participation Scale (BTPS)	Medical University of South Carolina|Health Resources and Services Administration (HRSA)	All	2 Years to 83 Months   (Child)	Not Applicable	80	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	00114600|R41MC42775-01-00	February 11, 2022	August 31, 2024	August 31, 2024	September 27, 2021		March 2, 2022	Medical University of South Carolina, Charleston, South Carolina, United States		https://ClinicalTrials.gov/show/NCT05056922
44	NCT01745497	Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder|Insomnia	Drug: Ferrous sulfate|Drug: Placebo	Improvement in sleep onset|Changes inDay time behavior|Improvements in sleep maintenance insomnia	University of Colorado, Denver|Autism Treatment Network|Massachusetts General Hospital|The Emmes Company, LLC|Health Resources and Services Administration (HRSA)	All	2 Years to 10 Years   (Child)	Phase 2	24	Other|Industry|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	12-0466	December 2012	August 2015	August 2015	December 10, 2012		August 3, 2020	Childrens Hospital Colorado, Aurora, Colorado, United States|University of Rochester, Rochester, New York, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|The Hospital for Sick Children, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT01745497
45	NCT04962659	Telehealth Mindfulness-Based Music and Songwriting for Parents of Children With Intellectual/Developmental Disabilities		Active, not recruiting	No Results Available	Parents|Stress|Developmental Disability|Intellectual Disability|Autism Spectrum Disorder	Behavioral: Mindfulness-Based Music and Songwriting	Perceived stress|Parent depression|Parent well-being|Parent mindfulness|Parent positive reappraisal|Parent anxiety|Parent affect regulation to MBMS sessions|Parent social connection to therapist at MBMS sessions|Parent daily momentary affect	Vanderbilt University Medical Center|National Endowment for the Arts, United States	All	18 Years and older   (Adult, Older Adult)	Not Applicable	34	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	18632783820	June 29, 2021	September 2022	September 2022	July 15, 2021		July 13, 2022	Vanderbilt University Medical Center, Nashville, Tennessee, United States		https://ClinicalTrials.gov/show/NCT04962659
46	NCT00902798	Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder	Perspectives	Completed	No Results Available	Autistic Disorder|Autism Spectrum Disorder|Asperger's Syndrome|Pervasive Developmental Disorder	Behavioral: Cognitive Enhancement Therapy|Behavioral: Enriched Supportive Therapy	Neurocognition|Social cognition|Functional outcome	University of Pittsburgh|National Institute of Mental Health (NIMH)|Autism Speaks|United States Department of Defense|Pennsylvania Department of Health	All	16 Years to 45 Years   (Child, Adult)	Not Applicable	54	Other|NIH|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	MH085851|R33MH085851|R21MH085851|AR100344|05381|2008NF-Autism|ARI2014	August 2010	April 2016	June 2017	May 15, 2009		April 13, 2020	University of Pittsburgh, Pittsburgh, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT00902798
47	NCT02149823	Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations		Suspended	No Results Available	Borderline Personality Disorder|BPD|Schizotypal Personality Disorder|SPD|Autism Spectrum Disorder|Schizophrenia|Schizoaffective Disorder|Bipolar Disorder	Drug: Syntocinon 24 Intranasal Units (IU)|Drug: Syntocinon 40 Intranasal Units (IU)|Drug: Intranasal Placebo	Movie for the Assessment of Social Cognition (MASC)|Reading of the Mind in the Eyes|Resting-state functional connectivity	Maria de las Mercedes Perez Rodriguez|James J. Peters Veterans Affairs Medical Center|VISN 3 Mental Illness Research, Education and Clinical Center|Icahn School of Medicine at Mount Sinai	All	18 Years to 65 Years   (Adult, Older Adult)	Phase 1	165	Other|U.S. Fed	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science	GCO 13-0340|UL1TR000067	September 2013	July 2022	July 2022	May 29, 2014		October 21, 2021	James J Peters VA Medical Center, Bronx, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States		https://ClinicalTrials.gov/show/NCT02149823
